Curigin Co., Ltd.
PrivateLast Round
VC Round
Apr 1, 2021
Est. Valuation
$59.64M
Total Funding Raised
$6.06M
Company Overview
Curigin Co., Ltd. is a biotechnology company that develops oncolytic virus-based gene therapies for treating cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curigin Co., Ltd. Comparables
Compare Curigin Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Akamis Bio | 79% | |
| ORCA Therapeutics | 78% | |
| Lokon Pharma | 78% |
Curigin Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2021 | ||||
| Series A | May 1, 2019 | ||||
| Seed | Mar 1, 2018 |
Curigin Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series A, Seed |
| Timefolio Asset Management | VC Round |
| Company K Partners | VC Round |
| Korea Investment Partners | Series A, Seed |
| Schmidt | Series A |
| Hana Securities | VC Round |
| LB Investment | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors increased 2049% MoM, reaching 2.7K.
- May 4, 2025
Monthly visitors grew 72% MoM, from 757 to 1.3K.
Curigin Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curigin Co., Ltd.'s valuation, stock price, and market status.
Is Curigin Co., Ltd. a public or private company?
Curigin Co., Ltd. is a private company.
What is the current stock price of Curigin Co., Ltd.?
Curigin Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Curigin Co., Ltd. worth (valuation)?
Curigin Co., Ltd.'s valuation is estimated at $59.6M based on funding round data.
Can I buy Curigin Co., Ltd. stock?
Curigin Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curigin Co., Ltd.'s last funding round?
Curigin Co., Ltd.'s most recent funding round was VC Round on April 1, 2021.
Who are the main investors in Curigin Co., Ltd.?
Key investors in Curigin Co., Ltd. include Timefolio Asset Management, LB Investment.
Will Curigin Co., Ltd. IPO soon?
No public IPO plans have been announced for Curigin Co., Ltd..
How can I track Curigin Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curigin Co., Ltd.'s secondary market activity and sign up for updates.